WELCOME TO THE DEPARTMENT OF PHARMACOLOGY

Introduction

The department of Pharmacology started with only one Professor in 2004, with the addition of another Professor and a Trainee Lecturer in 2005. Despite this, the discipline has been heavily involved in the initial development and later modification of the Faculty’s unique curriculum. We also played our part in helping the Faculty achieve accreditation by the Malaysian Qualification Agency in 2008.
 
Since then, department members have come and gone but the level of commitment of the discipline towards providing quality in teaching and learning remained high. To date, we have a dedicated set of lecturers who are focused in achieving the department’s and the Faculty’s mission and vision for the future.
 
Members of the pharmacology department have taken lead in key research areas. They are heavily involved with postgraduate training. The members are holding several internal and external grants and are supervising industrial, Master and PhD students. We also established the Research Interest Group “Molecular Pharmacology and Advanced Therapeutic” which has now been upgraded to Research Group under the Health and Wellness, Research Nexus UiTM (ReNeU).
 
One of the initiatives taken by the department is setting up a neuroscience lab in the faculty named Centre for Neuroscience Research (NeuRon) in 2014.  The lab is well equipped to cater for animal neuroscience and behavioural study.  It is located at Level 5 of the academic building of the Faculty, beside the Anatomy Laboratory. More information regarding this lab can be found here: Neuron

MEMBER OF PHARMACOLOGY DEPARTMENT

RESEARCH PROJECTS

Assoc. Prof. Dr. Anna Krasilnikova
Research Interest : Experimental and clinical Pharmacology of antimicrobial drugs, ocular Pharmacology and drug development. Currently the main research interests are focused on new applications of renin angiotensin system inhibitors in the field of ocular Pharmacology and treatment of glaucoma, as well as discovery of new antimicrobial and antiviral agents for the treatment of dengue, chikungunya and other RNA virus diseases.

Current Research Projects :
  1. Antioxidant Activity Of Novel N-substituted 5 (Phenylamino) Uracil   Derivatives In Chikungunya Virus Infected Vero Cells. 600-UiTMSEL (PI. 5/4) (018/2020).
  2. Mechanism of antiviral action of novel N-substituted 5-(phenylamino)uracil derivatives Z214 and Z364 targeting annexin A2. 600-RMC/GPK 5/3 (227/2020)
  3. Investigating the role of N-substituted 5-(phenylamino)uracil derivatives in annexin A2 as a possible mechanism of antiviral action against chikungunya virus: In vitro study. 600-UITMSEL (PI. 5/4) (053/2020).
  4. Characterization of antimicrobial peptides from the larvae of black soldier fly, Hermetia illucens (L.) (Diptera: Stratiomyidae) and blowfly, Chrysomya megacephala (F.) (Diptera: Calliphoridae).

OTHER PROJECTS

Presentation Skills Workshop

Surviving The Viva Seminar

A Campaign for Safe Use of Prescription Medicine

Updates on Antiviral Treatment of Global Viral Infections: Pharmacoepidemiology and Pharmacoeconomics (symposium)